EMPOWER

Globee® Awards Announces Winners in the 8th Annual 2021 International Best in Business Awards

Retrieved on: 
Wednesday, October 20, 2021
Woman, Organization, International Best Dressed Hall of Fame List, PDI, Dubai Health Authority, Marketing, IBM, Best, Golden Bridge, IPRA Golden World Awards, Women's World Award, Public relations, Cisco Systems, Globe Award, Commerzbank, Newage, Origanum onites, EMPOWER, SAN, Industry, Bridas Corporation, Xactly Corporation, CEO, Creativity, Pitcher, Philip Morris International, Sheffield Business Awards, Service Excellence Awards, Fannie Mae, Wool, Mobile phone

SAN FRANCISCO, Oct. 20, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 8th Annual 2021 International Best in Business Awards.

Key Points: 
  • SAN FRANCISCO, Oct. 20, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 8th Annual 2021 International Best in Business Awards.
  • This annual awards program celebrates the individuals and teams who set industry benchmarks for excellence.
  • Winners of Grand GLOBEE International Best in Business Awards include HALKBANK, IBM, Makers Nutrition, Pan American Energy, and Viettel Cambodia Pte.
  • Winners of one or more Gold GLOBEE International Best in Business Awards include NewAge, Inc., Pan American Energy, Emirates Central Cooling Systems Corporation (EMPOWER), Fannie Mae, New Heights Educational Group, IRONSCALES, Avalance Global Solutions, Commerzbank AG, IPification, Whatfix, BridgeComm, Inc., Viettel Cambodia Pte.

Operation Enduring Warrior Expands Its Mission

Retrieved on: 
Friday, October 1, 2021
Law enforcement, Veteran, Goal, Learning, Operation, Population, EMPOWER, Star Wars: X-Wing Alliance, Perseverance, Hardship, Athlete, Management

MIDLOTHIAN, Va., Oct. 1, 2021 /PRNewswire/ -- Operation Enduring Warrior took the first group of military honorees through an obstacle course race.

Key Points: 
  • MIDLOTHIAN, Va., Oct. 1, 2021 /PRNewswire/ -- Operation Enduring Warrior took the first group of military honorees through an obstacle course race.
  • Honorees are the "why" that drive the Operation Enduring Warrior mission.
  • No matter the role, they all work together to live the mission of Operation Enduring Warrior every day.
  • By expanding the population they serve, Operation Enduring Warrior is increasing the positive impact they make in the community.

SAN-EN NEOPHOENIX’s Thirdy Ravena to Continue as Project Ambassador

Retrieved on: 
Wednesday, September 29, 2021
Basketball, Cosmetics, Retail, Sports, Consumer, Men, Diamond, Social media, Partnership, Man, Policy, Hope, Courage, Multimedia, Sport, Optimism, Cosmetics, Nagoya Diamond Dolphins, Corporation, Athlete, GATSBY, Growth, Basketball, San-en NeoPhoenix, COVID-19, Ateneo de Manila University, EMPOWER, Uzbekistan Pro-B League, Airline

Mandom reports that a decision has been reached to re-engage with Thirdy Ravena, a player for the SAN-EN NEOPHOENIX B League basketball team, as the GGLC project ambassador.

Key Points: 
  • Mandom reports that a decision has been reached to re-engage with Thirdy Ravena, a player for the SAN-EN NEOPHOENIX B League basketball team, as the GGLC project ambassador.
  • The GGLC project in 2020 was begun to bring courage and energy to the people of Asia for the EMPOWER ASIA message.
  • Mandoms top partnership agreement with SAN-EN NEOPHOENIX has been renewed, and Thirdy Ravena will continue to serve as our project ambassador.
  • Mandoms hope is that this project will be a sense of optimism not only to young men but to all of the people of Asia.

ClinOne Brings Essential Technology to Cancer Clinical Trials with Single Platform for Oncologist Patient Referrals, eConsent, Uber Health, and More

Retrieved on: 
Wednesday, September 22, 2021
CONNECT, Clinical trial, Solution, HCPS, Transport, Cancer, Patient, LinkedIn, Caregiver, Inmate video visitation, Cros, Risk, Technology, Safety, Remote, INFORM, EMPOWER, Industry, Pharmaceutical industry, Medical imaging

DENVER, Sept. 22, 2021 /PRNewswire-PRWeb/ -- ClinOne , the patient relationship company for clinical trials, continues to expand its specialized technology solutions to support cancer patients, caregivers, sites, and study teams.

Key Points: 
  • DENVER, Sept. 22, 2021 /PRNewswire-PRWeb/ -- ClinOne , the patient relationship company for clinical trials, continues to expand its specialized technology solutions to support cancer patients, caregivers, sites, and study teams.
  • ClinOne's single platform, purpose-built for the unique needs and challenges of cancer trials, includes proven solutions for Oncologist referrals, eConsent, Uber Health, virtual visits, patient empowerment, and eDiaries.
  • "Put simply, they deserve better and as an industry, it is our responsibility to simplify the experience for them.
  • ClinOne is led by a team of experienced experts with decades of success running global trials for many of the largest technology providers.

Empagliflozin receives Breakthrough Therapy Designation in U.S. for heart failure with preserved ejection fraction (HFpEF)

Retrieved on: 
Thursday, September 9, 2021
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Health, Diabetes, Clinical Trials

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for empagliflozin as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced.

Key Points: 
  • The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for empagliflozin as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced.
  • Breakthrough Therapy Designation is testament to our commitment to the goal of improving outcomes for people affected by diseases across the cardio-renal-metabolic spectrum.
  • People with left-sided heart failure have either a reduced or a preserved ejection fraction.
  • Ejection fraction is a measurement of the percentage of blood the left ventricle pumps out with each contraction.17 When the heart relaxes, the ventricle refills with blood.

Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction

Retrieved on: 
Friday, August 27, 2021
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Health, Diabetes, Clinical Trials, People, Union, Empagliflozin, European Society of Cardiology, The New England Journal of Medicine, Population, Congress, Blood, Trial, Heart, EMPOWER, Congestion, Gaps, Hospital, Boehringer Ingelheim, Diabetes, European Union, LLY, Research, Heart failure, Hope, Disease, Man, Prevalence, Health, Berlin, Alliance, Death, Fatigue, Lilly, Chronic, SGLT2, NYSE, LVEF, Multimedia, Eli Lilly and Company, Risk, Mortality, Safety, News, ESC, Patient, Kidney disease, Corporation, Cardiovascular disease, Type 2 diabetes, New product development, Woman, Blood volume, Pharmaceutical industry, Medical imaging

This data brings hope for millions of patients suffering from heart failure with a preserved ejection fraction.

Key Points: 
  • This data brings hope for millions of patients suffering from heart failure with a preserved ejection fraction.
  • The risk of death in people with heart failure rises with each hospital admission and with kidney function decline.
  • The landmark EMPEROR-Preserved trial shows that empagliflozin brings significant benefit, which is incredibly exciting and welcome news for both the medical and patient communities.
  • If approved, empagliflozin would become the first clinically proven therapy across the full heart failure spectrum.

Black Women and Girl Athletes Take Center Stage on New Diverse Platform Launched by ONYX Media

Retrieved on: 
Thursday, August 26, 2021
Women, Automotive, Children, Software, Consumer, Social Media, Technology, Entertainment, General Sports, Publishing, African American, Tennis, Sports, Marketing, Online, Mobile Entertainment, Communications, General Automotive, Celebrity, LLC, Cadillac, Black Box (Brown Eyed Girls album), Program, Life, EMPOWER, Female, Marketing, USTA, Sport, Multimedia, Social justice, Environment, CEO, Sports Illustrated, Woman, Athlete, Entertainment, Management, Public relations

ONYX Media, LLC announced today the official launch of EMPOWER ONYX, a diverse multi-channel platform celebrating the stories and transformative power of sports for Black women and girls.

Key Points: 
  • ONYX Media, LLC announced today the official launch of EMPOWER ONYX, a diverse multi-channel platform celebrating the stories and transformative power of sports for Black women and girls.
  • The minority women owned media company aims to inspire young black women through in-depth profiles, articles, podcasts and documentaries showcasing leaders in sports who champion social justice, equality and self-empowerment.
  • We are excited to drive these authentic stories about incredible black women and girls through ONYX Media, said Melissa Grady, CMO Cadillac.
  • ONYX Media is a spin-off of GoodSport Media, Inc. a purpose driven content company focused on raising the visibility of women and girls in sports.